Oncology Exchange

PUBLIC PROFILE

Group Profile

ONCOLOGY EXCHANGE (ONCO X) is designing a comprehensive, yet easy to use technology solution to expand patient access to the vast global oncology science and practices already in play.

Recent Activity

June 14

June 10

June 07

May 17

Charles Decuir @Oncology Exchange: Metastatic colon cancer patient saved by aggressive treatmenthttps://www.bizjournals.com/k...

2 years ago

Charles Decuir @Oncology Exchange: Exploring Novel Mechanisms of Action–Then and Nowhttps://www.cancernetwork.co...

2 years ago

Charles Decuir @Oncology Exchange: Artificial intelligence-radiologist combo reduces missed lung cancer diagnoses by 60%https://www.radiologybusines...

2 years ago

Recent Posts

Oncology Exchange photo
Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities
A new option for the treatment of metastatic colorectal cancer, immune checkpoint inhibitor...
read more
Oncology Exchange photo
Novel Therapy Shows Promise in Group of Patients with Metastatic Colon Cancer
Patients with HER2-expressing metastatic colorectal cancer appeared to achieve durable and promising...
read more
Oncology Exchange photo
Provectus Biopharmaceuticals Announces Publication of In Vitro Data from Research on Oral Delivery of PV-10® at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
KNOXVILLE, TN, June 09, 2021 (GLOBE NEWSWIRE) — Provectus (OTCQB: PVCT) today announced that...
read more

see all posts